TNF-alpha inhibitors in combination with thiopurines have been associated with both B- and T-cell non-Hodgkin lymphomas when used in patients with inflammatory bowel disease (IBD) [10–12]. The gene discussed is TNF; the disease is T-cell non-Hodgkin lymphoma.